These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 25310198)
1. Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer. Liu X; Xiao Q; Bai X; Yu Z; Sun M; Zhao H; Mi X; Wang E; Yao W; Jin F; Zhao L; Ren J; Wei M Oncol Rep; 2014 Dec; 32(6):2760-8. PubMed ID: 25310198 [TBL] [Abstract][Full Text] [Related]
2. COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration. Boudot A; Kerdivel G; Lecomte S; Flouriot G; Desille M; Godey F; Leveque J; Tas P; Le Dréan Y; Pakdel F BMC Cancer; 2014 Jun; 14():407. PubMed ID: 24906407 [TBL] [Abstract][Full Text] [Related]
3. Role of B7-H4 siRNA in Proliferation, Migration, and Invasion of LOVO Colorectal Carcinoma Cell Line. Peng HX; Wu WQ; Yang DM; Jing R; Li J; Zhou FL; Jin YF; Wang SY; Chu YM Biomed Res Int; 2015; 2015():326981. PubMed ID: 26078947 [TBL] [Abstract][Full Text] [Related]
4. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Behera R; Kumar V; Lohite K; Karnik S; Kundu GC Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637 [TBL] [Abstract][Full Text] [Related]
5. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. Tan CT; Chu CY; Lu YC; Chang CC; Lin BR; Wu HH; Liu HL; Cha ST; Prakash E; Ko JY; Kuo ML Carcinogenesis; 2008 Aug; 29(8):1519-27. PubMed ID: 18487224 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis. Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662 [TBL] [Abstract][Full Text] [Related]
8. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway. Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281 [TBL] [Abstract][Full Text] [Related]
9. [Effects of JAK2/STAT3 signaling pathway on angiogenesis in non-small cell lung cancer]. Zhao M; Liu F; Wang JY; Zhang WY; Gao FH; Jiang B Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):375-81. PubMed ID: 21418908 [TBL] [Abstract][Full Text] [Related]
10. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis. Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666 [TBL] [Abstract][Full Text] [Related]
11. CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis. Sun Y; Mao X; Fan C; Liu C; Guo A; Guan S; Jin Q; Li B; Yao F; Jin F Tumour Biol; 2014 Aug; 35(8):7765-73. PubMed ID: 24810923 [TBL] [Abstract][Full Text] [Related]
12. C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2/STAT3. Zhang Q; Xu F; Shi Y; Chen YW; Wang HP; Yu X; Li Y Cell Biol Int; 2017 Aug; 41(8):854-862. PubMed ID: 28544312 [TBL] [Abstract][Full Text] [Related]
13. Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer. Yang DL; Xin MM; Wang JS; Xu HY; Huo Q; Tang ZR; Wang HF Genet Mol Res; 2015 Dec; 14(4):17699-707. PubMed ID: 26782415 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of potential Stat3-regulated genes in human breast cancer. Hsieh FC; Cheng G; Lin J Biochem Biophys Res Commun; 2005 Sep; 335(2):292-9. PubMed ID: 16081048 [TBL] [Abstract][Full Text] [Related]
15. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments. Liao YX; Fu ZZ; Zhou CH; Shan LC; Wang ZY; Yin F; Zheng LP; Hua YQ; Cai ZD Oncol Rep; 2015 Jul; 34(1):33-42. PubMed ID: 25997540 [TBL] [Abstract][Full Text] [Related]
16. The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma. Mazur G; Gębura K; Gieryng A; Butrym A; Wróbel T; Bogunia-Kubik K Cytokine; 2013 Oct; 64(1):422-6. PubMed ID: 23711392 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12. Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556 [TBL] [Abstract][Full Text] [Related]
18. Csk homologous kinase inhibits CXCL12-CXCR4 signaling in neuroblastoma. Zagozdzon R; Fu Y; Avraham HK Int J Oncol; 2008 Mar; 32(3):619-23. PubMed ID: 18292939 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway. Wang X; Qiu W; Zhang G; Xu S; Gao Q; Yang Z Int J Clin Exp Pathol; 2015; 8(5):5017-25. PubMed ID: 26191195 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2. Wang S; Chen X; Tang M Oncol Rep; 2014 Dec; 32(6):2824-30. PubMed ID: 25220761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]